Is Highmark's Digital Therapeutics Coverage a Game Changer for Investors

Medical technology stocks have declined from pandemic-era peaks as investor sentiment shifts. Market participants are now re-evaluating the sector's long-term growth potential and distinguishing medte...

Axsome Therapeutics is pursuing FDA approval for AUVELITY to treat agitation associated with Alzheimer's disease dementia. The company is currently discussing clinical data and regulatory pathways to ...

Hims & Hers and Teladoc Health are pursuing divergent growth strategies within the digital health sector. Investors are currently evaluating which firm offers superior upside potential based on their ...